Steinberg, G. D., Pearce, S., Belkoff, L., Mazzarella, B., Pieczonka, C. M., Shore, N. D., Henderson, J., Daneshmand, S., Bivalacqua, T. (2026). First results from CORE-008 cohort A: Phase 2 study of intravesical cretostimogene grenadenorepvec in patients with high-risk BCG-naïve non-muscle invasive bladder cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.756